Pilot Study of the Role of 11-dh-TXB2 in Prostate Cancer Screening and Diagnosis
- To identify a potential novel marker of prostate cancer in the blood and urine,
11-dh-TXB2, to be used as a screening tool for prostate cancer as well as in detection
of early relapse in patients previously treated for early-stage prostate cancer.
OUTLINE: Blood and urine samples are collected and analyzed for plasma and urinary
11-dh-TXB2 levels by HPLC and tandem-mass spectrometry.
Observational Model: Case Control, Time Perspective: Prospective
Identification of 11-dh-TXB2 in the blood and urine
2 to 4 months
Elisabeth I. Heath, MD
Barbara Ann Karmanos Cancer Institute
United States: Federal Government
|Barbara Ann Karmanos Cancer Institute||Detroit, Michigan 48201|